At the IGTP TODAY

News

DM1-Hub launches as a national multi-centre study to transform research and care for Myotonic Dystrophy type 1

On 2 June, IGTP hosted the kick-off event for the DM1-Hub, a multicentre project driven by the the group GRENBA, which aims to create a comprehensive national registry of patients with Myotonic Dystrophy type 1 (DM1). The event brought together researchers, clinical professionals, institutional representatives and patient associations from across Spain.

- Research

HDAC11 deficiency improves muscle function and regeneration during ageing

Researchers from GRENBA-IGTP have identified the HDAC11 protein, an enzyme involved in cellular regulation, as a new therapeutic target to combat sarcopenia, the loss of muscle mass associated with ageing. The study shows that HDAC11 deficiency reduces muscle atrophy, preserves the muscle stem cell reservoir, promotes regeneration after injury and improves muscle function, opening the door to new strategies to support healthy ageing.